189 related articles for article (PubMed ID: 10869364)
21. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice.
Vasandani C; Kafrouni AI; Caronna A; Bashmakov Y; Gotthardt M; Horton JD; Spady DK
J Lipid Res; 2002 May; 43(5):772-84. PubMed ID: 11971949
[TBL] [Abstract][Full Text] [Related]
23. ACAT inhibitors decrease secretion of cholesteryl esters and apolipoprotein B by perfused livers of African green monkeys.
Carr TP; Hamilton RL; Rudel LL
J Lipid Res; 1995 Jan; 36(1):25-36. PubMed ID: 7706945
[TBL] [Abstract][Full Text] [Related]
24. Protein synthesis inhibition in mouse peritoneal macrophages results in increased acyl coenzyme A:cholesterol acyl transferase activity and cholesteryl ester accumulation in the presence of native low density lipoprotein.
Tabas I; Boykow GC
J Biol Chem; 1987 Sep; 262(25):12175-81. PubMed ID: 3624250
[TBL] [Abstract][Full Text] [Related]
25. Trans-9-octadecenoic acid is biologically neutral and does not regulate the low density lipoprotein receptor as the cis isomer does in the hamster.
Woollett LA; Daumerie CM; Dietschy JM
J Lipid Res; 1994 Sep; 35(9):1661-73. PubMed ID: 7806980
[TBL] [Abstract][Full Text] [Related]
26. Manipulation of cholesterol and cholesteryl ester synthesis has multiple effects on the metabolism of apolipoprotein B and the secretion of very-low-density lipoprotein by primary hepatocyte cultures.
Brown A; Wiggins D; Gibbons GF
Biochim Biophys Acta; 1999 Sep; 1440(2-3):253-65. PubMed ID: 10521709
[TBL] [Abstract][Full Text] [Related]
27. Fatty acids regulate hepatic low density lipoprotein receptor activity through redistribution of intracellular cholesterol pools.
Daumerie CM; Woollett LA; Dietschy JM
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10797-801. PubMed ID: 1438279
[TBL] [Abstract][Full Text] [Related]
28. Hypolipidemic mechanisms of pectin and psyllium in guinea pigs fed high fat-sucrose diets: alterations on hepatic cholesterol metabolism.
Vergara-Jimenez M; Conde K; Erickson SK; Fernandez ML
J Lipid Res; 1998 Jul; 39(7):1455-65. PubMed ID: 9684749
[TBL] [Abstract][Full Text] [Related]
29. Regulation of hepatic cholesterol and lipoprotein metabolism in ethinyl estradiol-treated rats.
Erickson SK; Jaeckle S; Lear SR; Brady SM; Havel RJ
J Lipid Res; 1989 Nov; 30(11):1763-71. PubMed ID: 2614275
[TBL] [Abstract][Full Text] [Related]
30. Effects of bile salts on rat hepatic acyl CoA:cholesterol acyltransferase.
Erickson SK; Van Zuiden PE
Lipids; 1995 Oct; 30(10):911-5. PubMed ID: 8538378
[TBL] [Abstract][Full Text] [Related]
31. Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice.
Wang N; Arai T; Ji Y; Rinninger F; Tall AR
J Biol Chem; 1998 Dec; 273(49):32920-6. PubMed ID: 9830042
[TBL] [Abstract][Full Text] [Related]
32. Cholesterol absorption and hepatic acyl-coenzyme A:cholesterol acyltransferase activity play major roles in lipemic response to dietary cholesterol and fat in laboratory opossums.
Kushwaha RS; Vandeberg JF; Rodriguez R; Vandeberg JL
Metabolism; 2004 Jun; 53(6):817-22. PubMed ID: 15164335
[TBL] [Abstract][Full Text] [Related]
33. Dietary fat-induced alterations in atherosclerosis are abolished by ACAT2-deficiency in ApoB100 only, LDLr-/- mice.
Bell TA; Kelley K; Wilson MD; Sawyer JK; Rudel LL
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1396-402. PubMed ID: 17431188
[TBL] [Abstract][Full Text] [Related]
34. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.
Graham A; Wood JL; Russell LJ
Biochim Biophys Acta; 1996 Jul; 1302(1):46-54. PubMed ID: 8695654
[TBL] [Abstract][Full Text] [Related]
35. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of acyl-CoA: cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells.
Musanti R; Giorgini L; Lovisolo PP; Pirillo A; Chiari A; Ghiselli G
J Lipid Res; 1996 Jan; 37(1):1-14. PubMed ID: 8820097
[TBL] [Abstract][Full Text] [Related]
37. Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2 by beta-migrating very-low-density lipoprotein and non-lipoprotein cholesterol. Different cellular regulatory pools of cholesterol.
Kamps JA; van Berkel TJ
Eur J Biochem; 1992 Jun; 206(3):973-8. PubMed ID: 1318843
[TBL] [Abstract][Full Text] [Related]
38. Conjugated and non-conjugated octadecaenoic acids affect differently intestinal acyl coenzyme A: cholesterol acyltransferase activity.
Lam CK; Chen J; Cao Y; Yang L; Wong YM; Yeung SY; Yao X; Huang Y; Chen ZY
Atherosclerosis; 2008 May; 198(1):85-93. PubMed ID: 18078940
[TBL] [Abstract][Full Text] [Related]
39. Acyl-coenzyme A:cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, lecithin-cholesterol acyltransferase, SRB-1, and low-denisty lipoprotein receptor deficiencies in nephrotic syndrome.
Vaziri ND; Liang KH
Circulation; 2004 Jul; 110(4):419-25. PubMed ID: 15262831
[TBL] [Abstract][Full Text] [Related]
40. Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis.
Carr TP; Parks JS; Rudel LL
Arterioscler Thromb; 1992 Nov; 12(11):1274-83. PubMed ID: 1420087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
